INTERVENTIONAL CARDIOLOGY AN OVERVIEW

Slides:



Advertisements
Similar presentations
Prof Dr Rasim ENAR İÜ. CTF. Department of Cardiology
Advertisements

Acquired Heart Disease
Arterial Fibrodysplasia
Blood Pressure.
Ischaemic Heart Disease- Implications of Gender Dr Kaye Birks School of Rural Health Monash University Australia Gender Competency Training for Medical.
ISCHAEMIC HEART DISEASE Acute Coronary Syndromes JD Marx Department of Cardiology University of the Free State.
Coronary Artery Disease Megan McClintock. Coronary Artery Disease Definition Etiology/Pathophysiology Risk Factors –Unmodifiable –Modifiable Signs & symptoms.
Ischemic Heart Disease Group of diseases Most common cause of death in developed countries Terminology: 1.Angina pectoris 2.Myocardial infarction 3.Sudden.
Focusing on the Surgical Patient with Cardiac Problems By Kate J. Morse, RN, ACNP-BC, CCRN Nursing2009, March ANCC contact hours Online:
Modalities of Cardiac Stress Test
Ischemic heart disease
Ischemic Heart Diseases IHD
Assessment and management of patient with coronary artery disease
HEAPHY 1 & 2 CASE RACE 1 – DIAG Rowena OLIVER Sat 31 st Aug 2013 Session 3 / CR1-6 13:26 – 13:30 OTAGO / SOUTHLAND ABSTRACT A case of a 81 year old female.
Guidelines on Perioperative Cardiovascular Evaluation and Care for Noncardiac Surgery 2007 ACC/AHA and 2009 ESC GUIDELINES.
Stenting: Function, Problems, and Procedure. Uses for Stents  Peripheral artery disease (PAD)  Renal vascular hypertension  Hemodialysis access maintenance.
Angiography Excessive Commercialisation Complications of Angiography 1.Death 2.Myocardial Infarction Factors predisposing Unstable angina Angina at rest.
1 What is… ? Disparities Among Women in Acute Cardiac Care Frances Canet, MD Cath Conference Thursday, May 26, 2011.
Coronary Artery Disease Angina Pectoris Unstable Angina Variant Angina Joseph D. Lynch, MD.
Lesson 4 What is the treatment for Coronary Artery Disease?
C.H.T Dr.Salarifar 1 Tehran Heart Center Tehran University of Medical Sciences PCI VS CABG M. SALARIFAR, MD.
Ischemic heart disease. Indications and methods of surgical treatment. Surgery department №2.
Call for CASES Leszek D. Stachaczyk, MD Pawel Buszman, MD, FESC, FSCAI American Heart of Poland, Ustroñ, Poland & CCU, Upper-Silesian Center of Cardiology,
One stage coronary and peripheral intervention Pawel Buszman, MD, American Heart of Poland, Ustron Silesian Medical School, Katowice.
PCI Percutaneous Coronary Intervention prepared by: Sue Feltham RN, ACNP revised by: Amanda Darwood RN, BSc.
Indication and contra-indications for cardiac catheterization
Mosby items and derived items ©2009, 2007 by Mosby, Inc., an affiliate of Elsevier Inc. 1 Radiographic Pathology for Technologists, 5 th Edition Chapter.
Coronary Artery Disease Presented by: Marissa V. Dacumos Batch 17
VULNERABLE PLAQUES: Pertinent doubts and solutions in interventional cardiology EuroPCR Paris, 16 May 2006.
Cardio Investigations. Patients presenting with chest pain may be identified as having definite or possible angina from their history alone. Risk Factor.
Ischemic Heart Disease CVS3 Hisham Alkhalidi. Ischemic Heart Disease A group of related syndromes resulting from myocardial ischemia.
Pediatric Interventions Cardiac Catheterization and Valvuloplasty.
Cardiac Intervention in the Elderly. Cardiac Interventions Coronary Artery Bypass Grafting (CABG) Percutaneous Transluminal Coronary Angioplasty (PTCA)
CPORT- E Trial Randomized trial comparing outcomes of non-primary PCI at hospitals with and without on-site cardiac surgery.
Ischaemic Heart Disease. Aims and Objectives n Ischaemic heart disease –Definition, manifestations, epidemiology, aetiology, pathophysiology, risk factors.
ANGINA PECTORIS Tb Tuberculosis Carl Matol, RN. ANGINA-to choke CLASSIC/STABLE ANGINA Due to insufficiency of O2 supply against myocardial demand Accumulated.
TREATMENT OF ACUTE MYOCARDIAL INFARCTION NUR 351/352 PROFESSOR DIANE E. WHITE RN MS CCRN.
Angiography and Interventional Radiography Chapter 17.
Cardiovascular Monitoring Coronary Artery Disease.
Acute Coronary Syndromes. Learning outcomes To understand the clinical spectrum of coronary disease To recognise different presentations of the disease.
Dr C Raghu Interventional Cardiologist
Dr. Sohail Bashir Sulehria
 Heart disease remains the leading cause of morbidity and mortality in industrialized nations.  40% of all deaths in the U.S.A (nearly twice the number.
Coronary Heart Disease (CHD) László Tornóci Inst. Pathophysiology Semmelweis University.
ADMIRALADMIRAL Abciximab before Direct Angioplasty and Stenting in Myocardial Infarction Regarding Acute and Long term follow-up ADMIRAL Study ADMIRAL.
Ischemic Heart Disease CVS3 Hisham Alkhalidi. Ischemic Heart Disease A group of related syndromes resulting from myocardial ischemia.
Coronary Angiography, PCI & Cinemaps / Coronary Tree Diagrams Mike McAleer, Charge Nurse Manager CardioVascular Unit (CVU) July 2009.
Cardiopulmonary Disorders. Common Cardiac Disorders Coronary Artery Disease Myocardial Infarction (MI) Heart Murmurs/Valvular Heart Disease Congestive.
Myocardial Infarction Angina Pectoris What is an MI?
Myocardial Infarction (MI) Prepared by Miss Fatima Hirzallah RNS, MSN,CNS.
Elsevier Inc. items and derived items © 2010 by Saunders, an imprint of Elsevier Inc.1 Drugs for Angina Pectoris.
Ted Feldman MD, FACC, FESC, FSCAI Disclosure Information The following relationships exist: Grant support: Abbott, BSC, Edwards, St Jude, WL Gore Consultant:
Faramarz Amiri MD IUMS.  Severe carotid disease (defined as >80%) 8–12%  Severe carotid disease (>70%) in those with three vessel or left main coronary.
End points in PTCA trials. A successful angioplasty is defined as the reduction of a minimum stenosis diameter to
| rejuveindiameditour.com.
Date of download: 9/18/2016 Copyright © The American College of Cardiology. All rights reserved. From: Percutaneous Treatment of Protected and Unprotected.
Cardiovascular System Disorders
Revascularization of the Heart
Blood Supply to the Myocardium
ISCHEMIC HEART DISEASE
Complex Ostial Disease of the Aortic Arch Vessels
CORONARY ARTERY DISEASE
Catheter-Based Treatment of Coronary Artery Disease
Cardiac Cath NUR 422.
Chapter 28 Management of Patients With Coronary Vascular Disorders
Coronary Artery Disease and Acute Coronary Syndrome
Incidence And Management Of Restenosis After Treatment Of Unprotected Left Main Disease With Drug-Eluting Stents: 70 Restenotic Cases From A Cohort Of.
Incidence and management of restenosis after treatment of unprotected left main disease with drug-eluting stents: 70 restenotic cases from a cohort of.
Sirolimus Stent vs. Bare Stent in Acute Myocardial Infarction Trial
The American College of Cardiology Presented by Dr. A. Abazid
Presentation transcript:

INTERVENTIONAL CARDIOLOGY AN OVERVIEW Timothy P. Morris, D.O., F.A.C.C.

INTERVENTIONAL CARDIOLOGY DIAGNOSTIC CATHETERIZATION CORONARY ANGIOPLASTY AORTIC AND PERIPHERAL ANGIOPLASTY PERCUTANEOUS CLOSURE OF SHUNTS FOREIGN BODY REMOVAL STIMULATION OF COLLATERAL FORMATION

INTERVENTIONAL CARDIOLOGY UNITED STATES 1.2 MILLION DIAGNOSTIC CATHETERIZATIONS PER YEAR 480,000 CORONARY ANGIOPLASTIES PER YEAR 1 MILLION WORLDWIDE

INTERVENTIONAL CARDIOLOGY HISTORY FORSSMAN 1929 1st RIGHT HEART CATH ZIMMERMAN 1950 1st LEFT HEART CATH SELDINGER 1953 SONES 1958 GRUENTZIG 1977

INTERVENTIONAL CARDIOLOGY INDICATIONS ASYMPTOMATIC POSITIVE STRESS TEST SUDDEN CARDIAC DEATH INDIVIDUALS IN HIGH RISK PROFFESIONS PRIOR TO SURGERY WITH BORDERLINE POSITIVE NONINVASIVE STRESS TESTS AND RISK FACTORS

INTERVENTIONAL CARDIOLOGY SYMPTOMATIC FAILED MEDICAL THERAPY UNSTABLE ANGINA PECTORIS PRINZMETAL’S ANGINA ANGINA PECTORIS INTOLERANCE TO MEDS HIGH RISK OCCUPATION MARKEDLY ABNORMAL STRESS TEST PRIOR TO VASCULAR SURGERY

INTERVENTIONAL CARDIOLOGY ATYPICAL CHEST PAIN HIGH RISK NON-INVASIVE STUDIES SUSPECTED CORONARY VASOSPASM CONGESTIVE HEART FAILURE POST MYOCARDIAL INFARCTION FAILED THROMBOLYTIC THERAPY SUSPECTED COMPLICATIONS

INTERVENTIONAL CARDIOLOGY VALVULAR HEART DISEASE POSITIVE NON-INVASIVE STRESS TEST PRIOR TO VALVE REPLACEMENT MALES > 35 y.o. FEMALES > 40 y.o. CONGENITAL HEART DISEASE SUSPECTED CORONARY ANOMALIES MALES > 40 y.o., POST MENOPAUSAL FEMALES

INTERVENTIONAL CARDIOLOGY PROCEDURE ARTERIAL ACCESS VENOUS ACCESS LEFT HEART CATH RIGHT HEART CATH SELECTIVE CORONARY ANGIOGRAPHY

INTERVENTIONAL CARDIOLOGY LIMITATIONS OF ANGIOGRAPHY

INTERVENTIONAL CARDIOLOGY

INTERVENTIONAL CARDIOLOGY

INTERVENTIONAL CARDIOLOGY

INTERVENTIONAL CARDIOLOGY ULCERATED PLAQUE

INTERVENTIONAL CARDIOLOGY INDICATIONS FOR PTCA ASYMPTOMATIC , MILD SYMPTOMS SUDDEN CARDIAC DEATH SEVERE MYOCARDIAL ISCHEMIA FAILURE MEDICAL THERAPY INTOLERANT OF MEDICAL THERAPY PRIOR TO HIGH RISK SURGERY

INTERVENTIONAL CARDIOLOGY INDICATIONS FOR PTCA SYMPTOMATIC UNSTABLE ANGINA PECTORIS FAILED MEDICAL THERAPY LARGE AREA VIABLE MYOCARDIUM RESCUE PTCA PRIMARY PTCA IN ACUTE MI CARDIOGENIC SHOCK

INTERVENTIONAL CARDIOLOGY

INTERVENTIONAL CARDIOLOGY

INTERVENTIONAL CARDIOLOGY PTCA PROCEDURE FEMORAL ARTERIAL/ VENOUS ACCESS PLACE GUIDE CATHETER WIRE LESION BALLOON ANGIOPLASTY STENT “SEAL ARTERIOTOMY”

INTERVENTIONAL CARDIOLOGY PHARMACOLOGIC THERAPY ASPIRIN HEPARIN GLYCOPROTEIN 2B-3A INHIBITORS TICLID PLAVIX TREATMENT OF RISK FACTORS

INTERVENTIONAL CARDIOLOGY

INTERVENTIONAL CARDIOLOGY CONTRAINDICATIONS ABSOLUTE UNPROTECTED LEFT MAIN LESION LESS THEN 50% NO SURGICAL BACKUP RELATIVE DIFFUSELY DISEASED SVG DIFFUSELY DISEASED NATIVE VESSELS WITH GOOD DISTAL TARGETS

INTERVENTIONAL CARDIOLOGY CONTRAINDICATIONS RELATIVE (continued) BLEEDING DIASTHESIS PTCA OF NON-INFARCT VESSEL DURING PRIMARY PTCA HIGH RISK ANATOMY FOR ABRUPT CLOSURE SOLE VESSEL SUPPLYING HEART DIABETICS WITH MULTIVESSEL Dx

INTERVENTIONAL CARDIOLOGY MAJOR COMPLICATIONS DEATH (0.5%-1%) Q-WAVE MYOCARDIAL INFARCTION ( 1%-3%) EMERGENT SURGERY (1%)

INTERVENTIONAL CARDIOLOGY PROCEDURAL COMPLICATIONS ACUTE CLOSURE (4%-8%) SPASM THROMBUS DISECTION EMBOLISM TREATABLE WITH STENTS PERFORATION

INTERVENTIONAL CARDIOLOGY

INTERVENTIONAL CARDIOLOGY SHORT TERM RESULTS SUCCESS RATES (90%-95%) RESTENOSIS OCCURS IN 2-4 MONTHS ,RARE AFTER 6 MONTHS RATE (32%-57%) STENTS ( 20%-30%)

INTERVENTIONAL CARDIOLOGY

INTERVENTIONAL CARDIOLOGY

INTERVENTIONAL CARDIOLOGY LONG TERM RESULTS SURVIVAL 1 YEAR ( 97%) 5 YEARS (88%-97%) 10 YEARS (78%-90%) EVENT-FREE SURVIVAL 1 YEAR (81%-90%) 5 YEARS ( 79%) 10 YEARS ( 65%)

INTERVENTIONAL CARDIOLOGY NEW DEVICES STENTS DIRECTIONAL ATHERECTOMY ROTATIONAL ATHERECTOMY TRANSLUMINAL ATHERECTOMY ANGIOJET RADIATION PMR

INTERVENTIONAL CARDIOLOGY

INTERVENTIONAL CARDIOLOGY NIR STENT

C:\WINDOWS\All Users\Application Data\Microsoft\Works\Portfolio\Sample C:\WINDOWS\All Users\Application Data\Microsoft\Works\Portfolio\Sample.dir\70\Portfolio file 1.emf

INTERVENTIONAL CARDIOLOGY

INTERVENTIONAL CARDIOLOGY

INTERVENTIONAL CARDIOLOGY MITRAL VALVULOPLASTY

INTERVENTIONAL CARDIOLOGY CAROTID STENOSIS

INTERVENTIONAL CARDIOLOGY CAROTID STENOSIS AFTER STENTING

INTERVENTIONAL CARDIOLOGY SUBCLAVIAN STENOSIS

INTERVENTIONAL CARDIOLOGY SUBCLAVIAN STENOSIS POST PTA

INTERVENTIONAL CARDIOLOGY PTMR

INTERVENTIONAL CARDIOLGY SUMMARY RAPIDLY GROWING FIELD PTCA IDEAL FOR SINGLE VESSEL AND 2-VESSEL DISEASE WITHOUT PROXIMAL LAD INVOLVEMENT STENTS USED IN 80% PTCA CASES RESTENOSIS A LIMITING FACTOR NON-CORONARY PTA EXPANDING